Skip to main content
. 2017 Dec 14;39(7):1189–1196. doi: 10.1038/aps.2017.167

Table 2.

Biomarker levels in different subgroups of patients with heart failure (pg/mL for sST2, GDF-15 and uPAR, ng/mL for H-FABP).

Non smoking Smoking
Median Min Max Median Min Max P-value
sST2 3404 1742 6348 5116 1735 13207 0.04
H-FABP 2.18 0.00 367.00 2.22 0.86 387.00 0.92
GDF-15 739 338 2045 921 604 118257 0.24
suPAR 2184 1053 3648 2176 1372 3396 0.77
No angina pectoris Angina pectoris
Median Min Max Median Min Max P-value
sST2 3843 1735 13207 3837 2755 4919 0.93
H-FABP 2.29 0.00 387.00 1.99 1.31 2.67 0.64
GDF-15 761 338 2075 675 515 836 0.40
suPAR 2137 1053 3294 2330 1264 3396 0.93
No arterial hypertension Arterial hypertension
Median Min Max Median Min Max P-value
sST2 4803 1735 6530 3843 1742 13207 0.44
H-FABP 2.24 0.86 367.00 2.07 0.00 387.00 0.44
GDF-15 1108 632 118257 761 338 2075 0.18
suPAR 2137 1505 3294 2137 1053 3648 0.93
No type 2 diabetes Type 2 diabetes
Median Min Max. Median Min Max P-value
sST2 4065 1735 13207 4094 2258 7173 .80
H-FABP 2.33 0.86 367.00 2.10 0.00 387.00 .44
GDF-15 887 594 2045 802 338 118257 .69
suPAR 2079 1372 3156 2314 1053 3648 .41